Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)

NYSEARCA: TBXU · Real-Time Price · USD
30.86
+0.91 (3.03%)
At close: May 12, 2026, 4:00 PM EDT
30.86
0.00 (0.00%)
After-hours: May 12, 2026, 8:00 PM EDT
Assets$2.92M
Expense Ratio0.98%
PE Ration/a
Shares Out100,001
Dividend (ttm)$0.51
Dividend Yield1.66%
Ex-Dividend DateMar 24, 2026
Payout FrequencyQuarterly
Payout Ration/a
Volume2,279
Open31.00
Previous Close29.95
Day's Range30.86 - 31.38
52-Week Low25.71
52-Week High38.89
Betan/a
Holdings11
Inception DateOct 1, 2025

About TBXU

Fund Home Page

The Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol TBXU
ETF Provider Direxion
Index Tracked NYSE Biotechnology Top 5 Equal Weight Index

Top 10 Holdings

102.35% of assets
NameSymbolWeight
Dreyfus Govt Cash Man Insn/a29.68%
Goldman Finl Sq Trsry Inst 506n/a25.22%
argenx SEARGX10.03%
Regeneron Pharmaceuticals, Inc.REGN8.47%
Gilead Sciences, Inc.GILD8.24%
Vertex Pharmaceuticals IncorporatedVRTX8.07%
Amgen Inc.AMGN8.01%
Goldman Sachs Fin Gov 465 Institutn/a5.35%
Cashn/a0.00%
Dx D Biotech T 5 Bull 2x Etf Swapn/a-0.73%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Mar 24, 2026$0.09893Mar 31, 2026
Dec 23, 2025$0.10111Dec 31, 2025
Dec 10, 2025$0.31143Dec 17, 2025
Full Dividend History

Performance

News

Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs

New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...

Other symbols: TEXUTSXDTSXUTTXDTTXU
7 months ago - GlobeNewsWire